Jump Financial LLC Makes New Investment in Doximity, Inc. $DOCS

Key Points

• Jump Financial LLC has made a new investment in Doximity, Inc., purchasing 53,857 shares valued at approximately $3.1 million.
• Multiple large investors, including Vanguard Group and Invesco Ltd., have recently increased their positions in Doximity, indicating strong institutional interest with 87.19% of stock owned by such investors.
• Analysts are generally optimistic about Doximity, with two giving it a Strong Buy rating and a consensus price target of $66.21, reflecting a positive outlook for the company's growth.

Jump Financial LLC purchased a new position in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 53,857 shares of the company's stock, valued at approximately $3,125,000.

A number of other large investors also recently modified their holdings of the business. Vanguard Group Inc. raised its position in shares of Doximity by 8.8% during the 1st quarter. Vanguard Group Inc. now owns 12,194,492 shares of the company's stock worth $707,646,000 after purchasing an additional 990,923 shares during the period. Invesco Ltd. grew its position in shares of Doximity by 54.8% during the first quarter. Invesco Ltd. now owns 1,969,326 shares of the company's stock worth $114,280,000 after acquiring an additional 696,923 shares during the last quarter. Fuller & Thaler Asset Management Inc. boosted its stake in Doximity by 9.5% during the 1st quarter. Fuller & Thaler Asset Management Inc. now owns 1,730,282 shares of the company's stock valued at $100,408,000 after purchasing an additional 150,574 shares during the period. Dimensional Fund Advisors LP boosted its position in shares of Doximity by 4.2% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,576,455 shares of the company's stock worth $84,167,000 after buying an additional 63,815 shares during the period. Finally, Northern Trust Corp raised its position in shares of Doximity by 9.4% during the 4th quarter. Northern Trust Corp now owns 1,459,185 shares of the company's stock worth $77,906,000 after buying an additional 125,332 shares in the last quarter. 87.19% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

DOCS has been the topic of a number of research analyst reports. Raymond James Financial boosted their price target on shares of Doximity from $65.00 to $75.00 and gave the stock an "outperform" rating in a research report on Friday, August 8th. KeyCorp lifted their price target on Doximity from $65.00 to $70.00 and gave the stock an "overweight" rating in a research note on Monday, July 14th. Needham & Company LLC upped their price objective on shares of Doximity from $67.00 to $75.00 and gave the company a "buy" rating in a research note on Friday, August 8th. JPMorgan Chase & Co. decreased their target price on shares of Doximity from $63.00 to $60.00 and set a "neutral" rating for the company in a report on Tuesday, May 27th. Finally, Canaccord Genuity Group upped their price target on shares of Doximity from $50.00 to $59.00 and gave the company a "hold" rating in a research report on Friday, August 8th. Two analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating and eleven have issued a Hold rating to the stock. Based on data from MarketBeat, Doximity currently has an average rating of "Moderate Buy" and a consensus price target of $66.21.

Insider Activity

In other news, Director Kira Scherer Wampler sold 2,000 shares of the company's stock in a transaction on Friday, August 1st. The shares were sold at an average price of $57.09, for a total value of $114,180.00. Following the transaction, the director directly owned 16,618 shares of the company's stock, valued at approximately $948,721.62. This represents a 10.74% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Regina M. Benjamin sold 10,000 shares of the stock in a transaction on Wednesday, June 25th. The stock was sold at an average price of $60.00, for a total value of $600,000.00. Following the sale, the director owned 16,618 shares of the company's stock, valued at approximately $997,080. This represents a 37.57% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 36,000 shares of company stock worth $2,140,940 in the last ninety days. Corporate insiders own 31.30% of the company's stock.

Doximity Price Performance

Shares of DOCS opened at $67.13 on Wednesday. The business's 50-day moving average is $61.18 and its 200-day moving average is $60.45. The company has a market capitalization of $12.57 billion, a price-to-earnings ratio of 67.13, a P/E/G ratio of 4.10 and a beta of 1.36. Doximity, Inc. has a fifty-two week low of $35.32 and a fifty-two week high of $85.21.

Doximity (NASDAQ:DOCS - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The company reported $0.36 EPS for the quarter, beating analysts' consensus estimates of $0.31 by $0.05. Doximity had a net margin of 36.60% and a return on equity of 21.75%. During the same quarter in the prior year, the firm earned $0.28 EPS. Doximity's revenue was up 15.2% on a year-over-year basis. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. Equities research analysts expect that Doximity, Inc. will post 0.99 earnings per share for the current fiscal year.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.